Table Of Content

JOURNAL OF THE NEUROLOGICAL SCIENCES ELSEVIER Journal of the Neurological Sciences 137 (1996) 151-152 Author Index (Vol. 137) Ajimi, Y., see Ishikawa, M. (137) 109 Govitrapong, P., see Dumrongphol, H. (137) | Alfonso, G., see Kobayashi, H. (137) 131 Govoni, V., Granieri, E., Casetta, I., Tola, M.R., Paolino, E., Fainardi, E. Angelini, C., see Martinuzzi, A. (137) 14 and Monetti, V.C. The incidence of Guillain-Barré syndrome in Ferrara, Italy: Is the Balakrishnan, K.G., see Santoshkumar, B. (137) 139 disease really increasing? (137) 62 Barbiroli, B., see Fabrizi, G.M. (137) 20 Granieri, E., see Govoni, V. (137) 62 Barozzi, P., see Merelli, E. (137) 42 Guazzi, G., see Fabrizi, G.M. (137) 20 Bartoloni, L., see Martinuzzi, A. (137) 14 Borberg, H., see Haupt, W.F. (137) 145 Hattori, T., see Sakakibara, R. (137) 47 Bordessoule, D., see Vallat, J.M. (137) 124 Haupt, W.F., Rosenow, F., Van der Ven, C., Borberg, H. and Pawlik, G. Sequential treatment of Guillain-Barré syndrome with extracorporeal Cadaldini, M., see Martinuzzi, A. (137) 14 elimination and intravenous immunoglobulin (137) 145 Casetta, I., see Govoni, V. (137) 62 Heiss, W.-D., see Fink, G.R. (137) 28 Cavallaro, T., see Fabrizi, G.M. (137) 20 Hemachudha, T., see Dumrongphol, H. (137) | Couratier, P., see Vallat, J.M. (137) 124 Hoffman, E.P., see Kobayashi, H. (137) 131 Créange, A., Théodorou, I., Sabourin, J.-C., Vital, C., Farcet, J.-P. and Gherardi, R.K. Igata, A., see Yamamoto, M. (137) 117 Inflammatory neuromuscular disorders associated with chronic lym- Isaki, K., see Fukutani, Y. (137) 103 phoid leukemia: Evidence for clonal B cells within muscle and nerve Ishikawa, M., Ohira, T., Namiki, J., Ajimi, Y., Takase, M. and Toya, S. (137) 35 Abnormal muscle response (lateral spread) and F-wave in patients with hemifacial spasm (137) 109 D’Ettorre, M., see Fabrizi, G.M. (137) 20 Diener, P., see Wallstrém, E. (137) 89 Jauberteau, M.O., see Vallat, J.M. (137) 124 DiMauro, S., see Martinuzzi, A. (137) 14 Dubrovsky, A.L., see Fratantoni, S.A. (137) 97 Kachi, T., see Yamamoto, M. (137) 117 Dumrongphol, H., Srikiatkhachorn, A., Hemachudha, T., Kotchabhakdi, Kalita, J., see Misra, U.K. (137) 57 N. and Govitrapong, P. Katsura, K.-i., see Folbergrova, J. (137) 7 Alteration of muscarinic acetylcholine receptors in rabies viral-in- Khademi, M., see Wallstrém, E. (137) 89 fected dog brains (137) | Kim, J.S. Fabrizi, G.M., Lodi, R., D’Ettorre, M., Malandrini, A., Cavallaro, T., Cytokines and adhesion molecules in stroke and related diseases (137) Rimoldi, M., Zaniol, P., Barbiroli, B. and Guazzi, G. 69 Autosomal dominant limb girdle myopathy with ragged-red fibers and Kobayashi, H., Garcia, C.A., Alfonso, G., Marks, H.G. and Hoffman, E.P. cardiomyopathy. A pedigree study by in vivo *' PMR spectroscopy indicating a multisystem mitochondrial defect (137) 20 Molecular genetics of familial spastic paraplegia: a multitude of Fainardi, E., see Govoni, V. (137) 62 responsible genes (137) 131 Fanin, M., see Martinuzzi, A. (137) 14 Kobayashi, K., see Fukutani, Y. (137) 103 Farcet, J.-P., see Créange, A. (137) 35 Kotchabhakdi, N., see Dumrongphol, H. (137) | Fink, G.R., Pawlik, G., Stefan, H., Pietrzyk, U., Wienhard, K. and Heiss, W.-D. Ljungdahl, A., see Wallstrém, E. (137) 89 Temporal lobe epilepsy: Evidence for interictal uncoupling of blood Lodi, R., see Fabrizi, G.M. (137) 20 flow and glucose metabolism in temporomesial structures (137) 28 Folbergrova, J., Katsura, K.-i. and Siesjé, B.K. Malandrini, A., see Fabrizi, G.M. (137) 20 Glycogen accumulated in the brain following insults is not degraded Mandal, S.K., see Misra, U.K. (137) 57 during a subsequent period of ischemia (137) 7 Marks, H.G., see Kobayashi, H. (137) 131 Fratantoni, S.A., Dubrovsky, A.L. and Uchitel, O.D. Martinuzzi, A., Tsujino, S., Vergani, L., Schievano, G., Cadaldini, M., Uptake of immunoglobulin G from amyotrophic lateral sclerosis Bartoloni, L., Fanin, M., Siciliano, G., Shanske, S., DiMauro, S. and patients by motor nerve terminals in mice (137) 97 Angelini, C. Fukutani, Y., Nakamura, I., Matsubara, R., Kobayashi, K. and Isaki, K. Molecular characterization of myophosphorylase deficiency in a group Pathology of the cerebellar dentate nucleus in sporadic olivoponto- of patients from Northern Italy (137) 14 cerebellar atrophy: a morphometric investigation (137) 103 Matsubara, R., see Fukutani, Y. (137) 103 McDougall, A.J. and McLeod, J.G. Garcia, C.A., see Kobayashi, H. (137) 131 Autonomic neuropathy, |. Clinical features, investigation, pathophysi- Gherardi, R.K., see Créange, A. (137) 35 ology, and treatment (137) 79 Goto, K., see Mochizuki, H. (137) 120 McLeod, J.G., see McDougall, A.J. (137) 79 152 Author Index (Vol. 137) Merelli, E., Sola, P., Barozzi, P. and Torelli, G. Siciliano, G., see Martinuzzi, A. (137) 14 An encephalitic episode in a multiple sclerosis patient with human Siesj6, B.K., see Folbergrova, J. (137) 7 herpesvirus 6 latent infection (137) 42 Sola, P., see Merelli, E. (137) 42 Misra, U.K., Kalita, J., Srivastava, M. and Mandal, S.K. Srikiatkhachorn, A., see Dumrongphol, H. (137) | Prognosis of tuberculous meningitis: a multivariate analysis (137) 57 Srivastava, M., see Misra, U.K. (137) 57 Mizuno, Y., see Mochizuki, H. (137) 120 Stefan, H., see Fink, G.R. (137) 28 Mochizuki, H., Goto, K., Mori, H. and Mizuno, Y. Histochemical detection of apoptosis in Parkinson’s disease (137) 120 Takase, M., see Ishikawa, M. (137) 109 Monetti, V.C., see Govoni, V. (137) 62 Théodorou, I., see Créange, A. (137) 35 Mori, H., see Mochizuki, H. (137) 120 Tola, M.R., see Govoni, V. (137) 62 Torelli, G., see Merelli, E. (137) 42 Nakamura, I., see Fukutani, Y. (137) 103 Toya, S., see Ishikawa, M. (137) 109 Namiki, J., see Ishikawa, M. (137) 109 Tsujino, S., see Martinuzzi, A. (137) 14 Nilsson, C.-G., see Wallstrém, E. (137) 89 Uchitel, O.D., see Fratantoni, S.A. (137) 97 Ohira, T., see Ishikawa, M. (137) 109 Olsson, T., see Wallstrém, E. (137) 89 Vallat, J.M., Jauberteau, M.O., Bordessoule, D., Yardin, C., Preux, P.M. and Couratier, P. Paolino, E., see Govoni, V. (137) 62 Link between peripheral neuropathy and monoclonal dysglobuline- Pawlik, G., see Fink, G.R. (137) 28 mia: a study of 66 cases (137) 124 Pawlik, G., see Haupt, W.F. (137) 145 Van der Ven, C., see Haupt, W.F. (137) 145 Pietrzyk, U., see Fink, G.R. (137) 28 Vergani, L., see Martinuzzi, A. (137) 14 Preux, P.M., see Vallat, J.M. (137) 124 Vital, C., see Créange, A. (137) 35 Radhakrishnan, K., see Santoshkumar, B. (137) 139 Wallstrém, E., Diener, P., Ljungdahl, A., Khademi, M., Nilsson, C.-G. Rimoldi, M., see Fabrizi, G.M. (137) 20 Rosenow, F., see Haupt, W.F. (137) 145 and Olsson, T. Memantine abrogates neurological deficits, but not CNS inflamma- tion, in Lewis rat experimental autoimmune encephalomyelitis (137) Sabourin, J.-C., see Créange, A. (137) 35 89 Sakakibara, R., Hattori, T., Yasuda, K. and Yamanishi, T. Wienhard, K., see Fink, G.R. (137) 28 Micturitional disturbance after acute hemispheric stroke: analysis of the lesion site by CT and MRI (137) 47 Sankara Sarma, P., see Santoshkumar, B. (137) 139 Yamamoto, M., Kachi, T. and Igata, A. Santoshkumar, B., Radhakrishnan, K., Balakrishnan, K.G. and Pain-related somatosensory evoked potentials in dementia (137) 117 Sankara Sarma, P. Yamanishi, T., see Sakakibara, R. (137) 47 Neurologic complications of infective endocarditis observed in a Yardin, C., see Vallat, J.M. (137) 124 South Indian referral hospital (137) 139 Yasuda, K., see Sakakibara, R. (137) 47 Schievano, G., see Martinuzzi, A. (137) 14 Shanske, S., see Martinuzzi, A. (137) 14 Zaniol, P., see Fabrizi, G.M. (137) 20 JOURNAL OF THE NEUROLOGICAL SCIENCES BATS 45 ELSEVIER Journal of the Neurological Sciences 137 (1996) 153-154 Subject Index (Vol. 137) Acetylcholine, (137) 1 Immunoglobulin G, (137) 97 Adhesion molecule, (137) 69 Immunomodulatory treatment, (137) 145 Amyotrophic lateral sclerosis (ALS), (137) 97 Incidence update, (137) 62 Anatomy, (137) 79 Increasing rate, (137) 62 Anticipation, (137) 131 Infection, bacterial, (137) 139 Antiglycolipid antibody, (137) 124 Inflammatory myopathy, (137) 35 Apoptosis, (137) 120 In situ DNA nick-end labeling, (137) 120 Auditory event-related potentials, (137) 117 Interferon gamma (IFNy), (137) 89 Autonomic dysfunction, (137) 79 Intravenous immunoglobulin, (137) 145 Investigation, (137) 79 Cardiomyopathy, (137) 20 Cerebellar afferent system, (137) 103 Lateral spread, (137) 109 Cerebral blood flow, (137) 28 LICAM, (137) 131 Cerebral ischemia, (137) 69 Leukemia, (137) 35 Cerebrovascular accident, (137) 47 Limb girdle myopathy, (137) 20 Chemokine, (137) 69 Limbic, (137) 1 CO, laser, (137) 117 Complete ischemia, (137) 7 McArdle’s disease, (137) 14 Cytokine, (137) 69 Memantine, (137) 89 Meningitis, tuberculous: prognosis, (137) 57 Dementia, (137) 117 Methionine sulphoximine seizure, (137) 7 Dementia of Alzheimer’s type, (137) 117 Micturitional disturbance, (137) 47 Dentate nucleus, (137) 103 Mitochondrial encephalo-myopathy, (137) 20 Detrusor hyperreflexia, (137) 47 Monoclonal dysglobulinemia, (137) 124 Detrusor-sphincter dyssynergia, (137) 47 Morphometry, (137) 103 DM20, (137) 131 Motoneuron, (137) 97 Dog brain, (137) 1 3! PMR spectroscopy, (137) 20 Multiple sclerosis, (137) 42 Electrophysiology, (137) 109 Muscarinic receptor, (137) 1 Encephalitic, (137) 1 Muscle phosphorylase deficiency, (137) 14 Encephalitis, (137) 42 Myelin basic protein (MBP), (137) 89 Endocarditis, (137) 139 Experimental autoimmune encephalomyelitis (EAE), (137) 89 Nerve biopsy, (137) 124 Neurological deficit, (137) 89 Facial motonucleus, (137) 109 Neurologic complication, (137) 139 Familial spastic paraplegia, (137) 131 Neuron, (137) 103 Frontal lobe, (137) 47 N-methyl-D-aspartate (NMDA) receptor, (137) 89 F-wave, (137) 109 Pain-related evoked potentials, (137) 117 Genetic heterogeneity, (137) 131 Paralytic, (137) 1 Glucose metabolism, (137) 28 Paraneoplastic disorder, (137) 35 Glycogen degradation, (137) 7 Parkinson’s disease, (137) 120 Glycogenosis type V, (137) 14 Pathophysiology, (137) 79 Gray band, (137) 103 Pelizaeus—Merzbacher disease, (137) 131 Guillain-Barré syndrome, (137) 62 Peripheral neuropathy, (137) 35, (137) 79, (137) 124 Guillain-Barré syndrome, (137) 145 Plasma exchange, (137) 145 Polymerase chain reaction, (137) 35, (137) 42 Hemifacial spasm, (137) 109 Positron emission tomography, (137) 28 Hippocampal sclerosis, (137) 28 Proteolipid protein (PLP), (137) 131 Hippocampus, (137) 1 Human herpesvirus-6, (137) 42 Rabies, (137) 1 Hypoglycemic coma, (137) 7 Rumpshaker, (137) 131 Immunocytochemistry, (137) 97 Selective adsorption, (137) 145 Immunofluorescence, (137) 124 Sequential treatment, (137) 145 154 Subject Index (Vol. 137) Sporadic olivopontocerebellar atrophy, (137) 103 Treatment, (137) 79 Stroke, (137) 47, (137) 139 Tuberculosis, CNS, (137) 57 Uninhibited sphincter relaxation, (137) 47 Temporal lobe epilepsy, (137) 28 Uptake, (137) 97 Transient ischemia, (137) 7 Urodynamic study, (137) 47